Medicines as a strategic asset

EL PAÍS and Farmaindustria address the tasks pending to achieve autonomy in the manufacture of pharmaceuticals. Elpais.com Spain stands out for its strong pharmaceutical industry. It has 174 production plants, of which 106 are dedicated to medicines for human use and 13 to biological products. This ecosystem generates 51,000 direct and indirect jobs, with pharmaceuticals […]

SemFYC and Farmaindustria collaborate to promote clinical trials in Primary Care

A hundred members of the Spanish Society of Family and Community Medicine and pharmaceutical companies attend a training session to learn about the opportunities offered to patients by clinical research with drugs in this area of care. Spain has become an international leader in this field in recent years and the more than 13,000 primary […]

Farmaindustria promotes its project to increase clinical research in primary care in the autonomous communities of Spain.

After its presentation a few months ago in Andalusia, the guide to bring clinical trials to health centres has been disseminated in Castilla y León and at the National Congress of General and Family Medicine held in Galicia. The Association is also already working with other regional authorities who have shown interest in promoting clinical […]

Latin American countries interested in the successful model of clinical trials in Spain promoted by Farmaindustria

The Association has participated in the Forum on clinical trials organised by the United Nations in the Latin American and Caribbean region together with the Latin American Federation of the Pharmaceutical Industry and the Chamber of Pharmaceutical Innovation of Chile. Farmaindustria.es After years of collaborative work between health authorities, research hospitals, patients and pharmaceutical companies, […]

THESE ARE THE 10 REASONS WHY SPAIN IS A WORLD LEADER IN CLINICAL TRIALS

Spain is a benchmark country in the world and the first in Europe to conduct clinical trials to test the safety and efficacy of new drugs. The pandemic brought this activity closer to the general public, who are increasingly familiar with the importance of these studies, which are the last step in demonstrating the efficacy […]

The European Health Technology Assessment Regulation, an opportunity to speed up access to new medicines for patients in Spain

Its application should also serve to put an end to repetitive and inefficient evaluations and guarantee rigour for patients and healthcare professionals, who will play an important role in the evaluation procedure. Farmaindustria is organising a conference to analyse this regulation in depth and its translation to the national level at the European Parliament in […]

Farmaindustria launches Jóvenes en Farma, a web space to raise awareness of job opportunities in the sector and connect junior talent with companies

Recruitment forecasts for innovative pharmaceutical companies for the coming years exceed 10,000 new jobs for the under-30s. The website offers practical information about the sector and pharmaceutical companies, as well as keys to job orientation and training to bring young people closer to this industry. The project was presented this Tuesday at JoBarcelona, an employment […]

Precision medicine and new medicines require the modernisation of evaluation and funding processes, including the social perspective and the economic contribution to the country.

Funcas and Farmaindustria held a conference on ‘The economic regulation of the pharmaceutical industry. Current situation and future prospects in Spain’, which was attended by more than 300 people. Experts and authorities have analysed, among other issues, how future European pharmaceutical legislation and the Royal Decree on the evaluation of health technologies should be articulated. […]

Spain, a clinical trials powerhouse

Spain is at the forefront of research. Experts discuss the potential of new medicines at a forum organised by EL PAÍS and Farmaindustria. Elpais.com In the European panorama of clinical trials for new drugs, Spain stands out as a benchmark. Of the 2,500 trials carried out in the region last year, 45% were conducted in […]

Innovation as a patients’ right

DemócrataPRO brings together the Health Commission to debate on the reform of the law on medicines On 21 March, DemócrataPro brought together the spokespersons of the Health Commission of the Spanish Congress of Deputies to reflect on innovation as a patients’ right in the context of the drug reform announced by the Minister of Health, […]